Why the study?
Are platelet factor 4 (PF4) and β-thromboglobulin (β-TG) levels elevated in patients with ischemic heart disease compared to normal controls?
Are platelet factor 4 (PF4) and β-thromboglobulin (β-TG) levels elevated in patients with ischemic heart disease compared to normal controls?
PF4 and β-TG are elevated in acute myocardial infarction but not angina pectoris, serving as useful biomarkers for in vivo platelet activation.
Answers are grounded in this paper and cite their sources.
Supports platelet activation in acute MI; leaves open biomarker validation in prospective cohorts.
The platelet factor 4 (PF4) and β-thromboglobulin (β-TG) were measured to evaluate the platelet activation in vivo in patients with ischemic heart disease. The results are summarized as follows: In patients with acute myocardial infarction, the PF4 and the β-TG levels were significantly higher compared to those of normal controls (P<0.005).In patients with angina pectoris, the PF4 and the β-TG levels were not signivicantly different from those of normal controls.A pattern of decline in the PF4 and the β-TG level was shown in patients with acute myocardial infarction by day 10. In conclusion, the measurement of PF4 and β-TG is a useful method to detect the platect activation in vivo in the patients with ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Kim et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: